Aura Biosciences Inc (NAS:AURA)
$ 8.74 0.16 (1.86%) Market Cap: 433.56 Mil Enterprise Value: 257.24 Mil PE Ratio: 0 PB Ratio: 2.26 GF Score: 22/100

Aura Biosciences Inc Investor Day Transcript

Oct 03, 2022 / 03:30PM GMT
Release Date Price: $14.59 (-19.48%)
Operator

Good morning. My name is Chantal, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Aura Biosciences Virtual Investor Day. (Operator Instructions) As a reminder, today's call is being recorded.

I would now like to turn the call over to Elisabet de los Pinos, Chief Executive Officer of Aura Biosciences.

Elisabet de los Pinos
Aura Biosciences, Inc. - Founder, CEO, President & Director

Yes. Thank you. Welcome to Aura Investor Day. We're excited. We have a very good agenda for the day. As you know, we are back from Chicago, where we had exciting data of our suprachoroidal administration with AU-011 Bel-Sar.

We have today the privilege to welcome 3 of the top key opinion leaders in the field of ocular oncology, and they will share with you their perspective, their opinion on our drug and in general, in the field of ocular oncology. And afterwards, we will have a moderated Q&A, and we look forward to all your questions.

So let me give you a brief overview of Aura. as you all know,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot